Nomura Holdings
TCRT icon

Nomura Holdings’s Alaunos Therapeutics TCRT Stock Holding History

Nomura Holdings’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-465
Closed -$353K – 2240
2014
Q4 		$353K Sell
465
-528
-53% -$280K ﹤0.01% 1790
2014
Q3 		$394K Buy
993
+639
+181% +$308K ﹤0.01% 1993
2014
Q2 		$215K Buy
354
+103
+41% +$57.3K ﹤0.01% 2337
2014
Q1 		$174K Buy
+251
New +$168K ﹤0.01% 2381
2013
Q4 		– Sell
-295
Closed -$173K – 2304
2013
Q3 		$173K Buy
+295
New +$133K ﹤0.01% 1952

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings's TCRT Position: Q1 2015 in Review

Nomura Holdings sold out of Alaunos Therapeutics (TCRT) in Q1 2015, closing a stake of 465 shares — an estimated $353K sold.

Nomura Holdings first reported a position in TCRT in Q3 2013 and held it in 5 quarters. The position peaked at $394K in Q3 2014. 128 funds tracked by Wall St. Rank hold TCRT as of Q1 2015.

  • Nomura Holdings reported no remaining Alaunos Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Nomura Holdings sold 465 Alaunos Therapeutics shares in Q1 2015, an estimated $353K.
  • Nomura Holdings first reported a position in Alaunos Therapeutics in Q3 2013 and held it in 5 quarters.
  • Nomura Holdings's Alaunos Therapeutics position peaked at $394K in Q3 2014.
  • 128 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2015.

Based on Nomura Holdings's 13F filing for Q1 2015, filed 15 May 2015.